Argitalpenak (61)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure

    Medical mycology, Vol. 61, Núm. 5

  3. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  4. Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228

    Journal of Fungi

  5. Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato

    Mycoses, Vol. 66, Núm. 3, pp. 196-201

  6. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

    Open Forum Infectious Diseases, Vol. 10, Núm. 2

  7. The Gastrointestinal Tract Is Pinpointed as a Reservoir of Candida albicans, Candida parapsilosis, and Candida tropicalis Genotypes Found in Blood and Intra-Abdominal Samples

    Journal of Fungi, Vol. 9, Núm. 7

2022

  1. Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3102-3109

  2. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis

    Journal of Fungi, Vol. 8, Núm. 11

  3. Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic

    Frontiers in Medicine, Vol. 9

  4. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

  5. EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings

    Antimicrobial agents and chemotherapy, Vol. 66, Núm. 9, pp. e0084922

  6. Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8

  7. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B

    Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1291.e7-1291.e10

  8. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  9. Screening of azole resistance in Aspergillus fumigatus using the EUCAST E.Def 10.2 azole-containing agar method: A single study suggests that filtration of conidial suspensions prior to inoculum preparation may not be needed

    Mycoses, Vol. 65, Núm. 11, pp. 1045-1049

2021

  1. Antifungal susceptibility testing identifies the abdominal cavity as a source of candida glabrata-resistant isolates

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 12

  2. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  3. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  4. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

    Clinical Microbiology and Infection